QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
BA   237.20 (+5.96%)
NFLX   497.52 (-1.16%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
BA   237.20 (+5.96%)
NFLX   497.52 (-1.16%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
BA   237.20 (+5.96%)
NFLX   497.52 (-1.16%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
BA   237.20 (+5.96%)
NFLX   497.52 (-1.16%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
Log in
NASDAQ:ARWR

Arrowhead Pharmaceuticals News Headlines

$63.98
-0.74 (-1.14 %)
(As of 12/3/2020 12:00 AM ET)
Add
Compare
Today's Range
$63.50
Now: $63.98
$65.00
50-Day Range
$44.46
MA: $61.64
$70.79
52-Week Range
$19.51
Now: $63.98
$72.50
Volume514,798 shs
Average Volume1.44 million shs
Market Capitalization$6.57 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.62

Headlines

Arrowhead Pharmaceuticals (NASDAQ ARWR) News Headlines Today

Source:
SourceHeadline
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to "Hold" by BidaskClubArrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to "Hold" by BidaskClub
marketbeat.com - October 28 at 3:06 AM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Given New $31.00 Price Target at SVB LeerinkArrowhead Pharmaceuticals (NASDAQ:ARWR) Given New $31.00 Price Target at SVB Leerink
marketbeat.com - September 17 at 8:33 AM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns "Buy" Rating from HC WainwrightArrowhead Pharmaceuticals (NASDAQ:ARWR) Earns "Buy" Rating from HC Wainwright
marketbeat.com - August 27 at 6:28 AM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to Buy by ValuEngineArrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to Buy by ValuEngine
marketbeat.com - August 22 at 2:12 AM
Arrowhead Pharmaceuticals Shares Point North (NASDAQ: ARWR) (ARWR)Arrowhead Pharmaceuticals Shares Point North (NASDAQ: ARWR) (ARWR)
marketbeat.com - August 3 at 2:08 PM
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Recommendation of "Buy" from BrokeragesArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Recommendation of "Buy" from Brokerages
americanbankingnews.com - December 1 at 10:37 AM
New Forecasts: Heres What Analysts Think The Future Holds For Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)New Forecasts: Here's What Analysts Think The Future Holds For Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
finance.yahoo.com - November 28 at 8:04 AM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 10.5%Arrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 10.5%
americanbankingnews.com - November 27 at 7:12 PM
This Insider Has Just Sold Shares In Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)This Insider Has Just Sold Shares In Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
nasdaq.com - November 27 at 8:58 AM
Brokers Set Expectations for Arrowhead Pharmaceuticals, Inc.s FY2021 Earnings (NASDAQ:ARWR)Brokers Set Expectations for Arrowhead Pharmaceuticals, Inc.'s FY2021 Earnings (NASDAQ:ARWR)
americanbankingnews.com - November 26 at 9:06 AM
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) to Post Q1 2021 Earnings of ($0.13) Per Share, Piper Sandler ForecastsArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) to Post Q1 2021 Earnings of ($0.13) Per Share, Piper Sandler Forecasts
americanbankingnews.com - November 26 at 8:04 AM
Earnings Beat: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsEarnings Beat: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
nasdaq.com - November 26 at 7:25 AM
Arrowhead Pharmaceuticals Announces Closing of Agreement with TakedaArrowhead Pharmaceuticals Announces Closing of Agreement with Takeda
finance.yahoo.com - November 25 at 8:33 AM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) versus Oasmia Pharmaceutical AB (publ) (OTCMKTS:OASMY) Head-To-Head ContrastArrowhead Pharmaceuticals (NASDAQ:ARWR) versus Oasmia Pharmaceutical AB (publ) (OTCMKTS:OASMY) Head-To-Head Contrast
americanbankingnews.com - November 24 at 11:12 PM
Noteworthy Tuesday Option Activity: ARWR, SYNH, XECNoteworthy Tuesday Option Activity: ARWR, SYNH, XEC
nasdaq.com - November 24 at 5:32 PM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) PT Raised to $80.00Arrowhead Pharmaceuticals (NASDAQ:ARWR) PT Raised to $80.00
americanbankingnews.com - November 24 at 10:59 AM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) PT Lowered to $34.00 at SVB LeerinkArrowhead Pharmaceuticals (NASDAQ:ARWR) PT Lowered to $34.00 at SVB Leerink
americanbankingnews.com - November 24 at 8:21 AM
Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q4 2020 Results - Earnings Call TranscriptArrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - November 24 at 1:47 AM
Recap: Arrowhead Pharmaceuticals Q4 EarningsRecap: Arrowhead Pharmaceuticals Q4 Earnings
finance.yahoo.com - November 23 at 8:47 PM
Arrowhead Pharmaceuticals, Inc. to Host Earnings CallArrowhead Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 23 at 3:44 PM
Insider Selling: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Insider Sells 19,500 Shares of StockInsider Selling: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Insider Sells 19,500 Shares of Stock
americanbankingnews.com - November 20 at 8:46 PM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Now Covered by Smith Barney CitigroupArrowhead Pharmaceuticals (NASDAQ:ARWR) Now Covered by Smith Barney Citigroup
americanbankingnews.com - November 19 at 12:22 PM
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Coverage Initiated at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellArrowhead Pharmaceuticals (NASDAQ:ARWR) Coverage Initiated at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell
americanbankingnews.com - November 19 at 10:37 AM
TBJ Plus: Triangle companies on elite list; More Wegmans opening dates; Wings spot adds Raleigh locationTBJ Plus: Triangle companies on elite list; More Wegmans opening dates; Wings spot adds Raleigh location
bizjournals.com - November 18 at 2:49 PM
B. Riley Raises Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target to $98.00B. Riley Raises Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target to $98.00
americanbankingnews.com - November 17 at 1:02 PM
Robert W. Baird Increases Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target to $75.00Robert W. Baird Increases Arrowhead Pharmaceuticals (NASDAQ:ARWR) Price Target to $75.00
americanbankingnews.com - November 16 at 10:29 AM
Arrowhead Pharmas RNAi therapy shows benefit in rare liver disease studyArrowhead Pharma's RNAi therapy shows benefit in rare liver disease study
seekingalpha.com - November 13 at 1:43 PM
Arrowhead Pharmaceuticals to Participate in Upcoming ConferencesArrowhead Pharmaceuticals to Participate in Upcoming Conferences
finance.yahoo.com - November 9 at 7:36 AM
Arrowhead KOL events on cardiometabolic candidates November 18-19Arrowhead KOL events on cardiometabolic candidates November 18-19
seekingalpha.com - November 4 at 9:21 AM
Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3
finance.yahoo.com - November 4 at 9:21 AM
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Year End ResultsArrowhead Pharmaceuticals to Webcast Fiscal 2020 Year End Results
finance.yahoo.com - November 2 at 7:29 PM
Arrowhead Stock Is Up 16x Since 2017, And The Rally Is Far From OverArrowhead Stock Is Up 16x Since 2017, And The Rally Is Far From Over
forbes.com - October 30 at 8:49 AM
Why Arrowhead Pharmaceuticals Stock Jumped TodayWhy Arrowhead Pharmaceuticals Stock Jumped Today
finance.yahoo.com - October 23 at 3:02 PM
Thinking about trading options or stock in General Electric, Roku, CareDx Inc, Arrowhead Pharmaceuticals, or Eli Lilly?Thinking about trading options or stock in General Electric, Roku, CareDx Inc, Arrowhead Pharmaceuticals, or Eli Lilly?
benzinga.com - October 9 at 8:10 AM
Takeda Broadens Its Rare Disease Portfolio By Partnering With ArrowheadTakeda Broadens Its Rare Disease Portfolio By Partnering With Arrowhead
seekingalpha.com - October 8 at 2:24 PM
Takeda and Arrowhead Pharmaceuticals join hands to treat liver diseaseTakeda and Arrowhead Pharmaceuticals join hands to treat liver disease
seekingalpha.com - October 8 at 9:23 AM
Takeda and Arrowhead Pharmaceuticals team up in rare liver diseaseTakeda and Arrowhead Pharmaceuticals team up in rare liver disease
seekingalpha.com - October 8 at 9:23 AM
Takeda, Arrowhead Ink Collaboration And Licensing Deal To Develop ARO-AATTakeda, Arrowhead Ink Collaboration And Licensing Deal To Develop ARO-AAT
nasdaq.com - October 8 at 9:23 AM
After big buyout, team looks to lead hepatitis B, NASH drug maker to $100M IPOAfter big buyout, team looks to lead hepatitis B, NASH drug maker to $100M IPO
bizjournals.com - September 29 at 12:27 AM
ARWR: Better Than Anticipated Interim Data for ARO-AAT…ARWR: Better Than Anticipated Interim Data for ARO-AAT…
finance.yahoo.com - September 21 at 12:20 PM
Why This Interim Liver Study Is Huge for Arrowhead PharmaWhy This Interim Liver Study Is Huge for Arrowhead Pharma
msn.com - September 16 at 2:39 PM
Arrowhead Pharmaceuticals to Participate in Upcoming September 2020 ConferencesArrowhead Pharmaceuticals to Participate in Upcoming September 2020 Conferences
finance.yahoo.com - September 8 at 8:19 AM
Arrowhead Pharmaceuticals Appoints Oye Olukotun to Board of DirectorsArrowhead Pharmaceuticals Appoints Oye Olukotun to Board of Directors
finance.yahoo.com - September 8 at 8:19 AM
Estimating The Intrinsic Value Of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)Estimating The Intrinsic Value Of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
finance.yahoo.com - September 7 at 7:16 AM
Arrowhead Pharmaceuticals (ARWR) Presents At Virtual ESC Congress 2020 - SlideshowArrowhead Pharmaceuticals (ARWR) Presents At Virtual ESC Congress 2020 - Slideshow
seekingalpha.com - August 31 at 6:32 PM
Arrowhead reports encouraging data on cardiometabolic candidates ARO-APOC3 and ARO-ANG3Arrowhead reports encouraging data on cardiometabolic candidates ARO-APOC3 and ARO-ANG3
seekingalpha.com - August 31 at 8:20 AM
Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data on Investigational Hepatitis B Therapeutic JNJ-3989 at The Digital Liver CongressArrowhead and Collaborator Janssen Present Phase 2 Clinical Data on Investigational Hepatitis B Therapeutic JNJ-3989 at The Digital Liver Congress
finance.yahoo.com - August 28 at 8:15 AM
Arrowhead Pharma launches early-stage study of RNAi drug in kidney cancerArrowhead Pharma launches early-stage study of RNAi drug in kidney cancer
seekingalpha.com - August 18 at 12:49 PM
Arrowhead Pharmaceuticals to Participate in Upcoming August 2020 ConferencesArrowhead Pharmaceuticals to Participate in Upcoming August 2020 Conferences
finance.yahoo.com - August 18 at 12:49 PM
Arrowhead launches study of RNAi drug in cystic fibrosisArrowhead launches study of RNAi drug in cystic fibrosis
seekingalpha.com - August 11 at 3:39 PM
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic FibrosisArrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
finance.yahoo.com - August 11 at 3:39 PM
Arrowhead Pharmaceuticals: Now The Best Biotech Stock With Near-Term Capital Gain ProspectsArrowhead Pharmaceuticals: Now The Best Biotech Stock With Near-Term Capital Gain Prospects
seekingalpha.com - August 10 at 11:03 PM
ARWR: Biopsy Data from ARO-AAT Trial Before Year End 2020…ARWR: Biopsy Data from ARO-AAT Trial Before Year End 2020…
finance.yahoo.com - August 10 at 12:58 PM
Arrowhead FQ3 revenue shy of consensus despite $20M Amgen milestoneArrowhead FQ3 revenue shy of consensus despite $20M Amgen milestone
seekingalpha.com - August 5 at 5:47 PM
Arrowhead bags $20M milestone from Amgen on advancement of AMG 890Arrowhead bags $20M milestone from Amgen on advancement of AMG 890
seekingalpha.com - July 29 at 10:02 AM
This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.